UEEC— United Health Products, Inc.

$11M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Revenues	$0	$0	$0-100.0%	$38K
Selling, general and administrative expenses	$2.0M+20.2%	$1.7M-9.6%	$1.8M-16.8%	$2.2M
Research and development expenses	$270K-24.2%	$356K-40.6%	$599K-4.1%	$625K
Total Operating Expenses	$2.3M+12.3%	$2.0M-17.3%	$2.4M-14.0%	$2.8M
Loss from Operations	-$2.3M-12.3%	-$2.0M+17.3%	-$2.4M+13.4%	-$2.8M
Interest expense	-$113K-250.5%	-$32K+20.2%	-$41K-138.0%	-$17K
Interest expense - related party	-$87K-13.0%	-$77K-1.6%	-$76K-22.4%	-$62K
Gain (loss) on derivative liabilities	$28K	$0	—	—
Fraud loss	-$242K	$0	—	—
Gain (loss) on settlement of debt	$0-100.0%	$115K+242.9%	-$81K+61.6%	-$210K
Total Other Income (Expense)	-$414K-7188.1%	$6K+103.0%	-$197K-117.7%	$1.1M
Income tax expense	$0	$0	$0	$0
Net Loss	-$2.7M-33.4%	-$2.0M+23.7%	-$2.6M-55.5%	-$1.7M
Basic and diluted	-$0.01+0.0%	-$0.01+0.0%	-$0.01+0.0%	-$0.01
Weighted average number of shares outstanding	257.0M+3.5%	248.2M+3.8%	239.1M+4.1%	229.7M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 12 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.